Statutory Profit Doesn't Reflect How Good PKU HealthCareLtd's (SZSE:000788) Earnings Are

PKU HealthCare Corp.,Ltd. (SZSE:000788) recently posted some strong earnings, and the market responded positively. Our analysis found some more factors that we think are good for shareholders.

Check out our latest analysis for PKU HealthCareLtd

earnings-and-revenue-history
SZSE:000788 Earnings and Revenue History May 2nd 2024
Advertisement

How Do Unusual Items Influence Profit?

Importantly, our data indicates that PKU HealthCareLtd's profit was reduced by CN¥23m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect PKU HealthCareLtd to produce a higher profit next year, all else being equal.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of PKU HealthCareLtd.

Our Take On PKU HealthCareLtd's Profit Performance

Because unusual items detracted from PKU HealthCareLtd's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think PKU HealthCareLtd's earnings potential is at least as good as it seems, and maybe even better! And the EPS is up 30% annually, over the last three years. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. You can see our latest analysis on PKU HealthCareLtd's balance sheet health here.

This note has only looked at a single factor that sheds light on the nature of PKU HealthCareLtd's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SZSE:000788

PKU HealthCareLtd

Engages in the research and development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China.

Flawless balance sheet and good value.

Advertisement

Weekly Picks

VA
valuebull
GOAI logo
valuebull on Eva Live ·

Is this the AI replacing marketing professionals?

Fair Value:US$7.4344.8% undervalued
21 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
ZA
PME logo
ZayaanS on Pro Medicus ·

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value:AU$196.7832.6% undervalued
28 users have followed this narrative
5 users have commented on this narrative
18 users have liked this narrative
ST
WBD logo
SteveGruber on Warner Bros. Discovery ·

The Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery  

Fair Value:US$18.1753.8% overvalued
5 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
PD
VRT logo
pdixit1 on Vertiv Holdings Co ·

The Infrastructure AI Cannot Be Built Without

Fair Value:US$408.6440.8% undervalued
32 users have followed this narrative
3 users have commented on this narrative
15 users have liked this narrative

Updated Narratives

AN
andre_santos
HIMS logo
andre_santos on Hims & Hers Health ·

Hims & Hers Health - Valuation

Fair Value:US$29.2146.1% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PA
TSLA logo
Parul on Tesla ·

Tesla will achieve a 392% PE ratio increase according to recent forecasts

Fair Value:US$371.696.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PE
penelopewheeler
LYC logo
penelopewheeler on Lynas Rare Earths ·

Lynas Rare Earths: Owning the Policy-Backed Growth Regime, Not Just the Ore Body.

Fair Value:AU$2320.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.377.3% undervalued
49 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0229.7% undervalued
1101 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59631.4% undervalued
1297 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative